The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $76.10

Today's change+0.20 +0.26%
Updated January 22 3:14 PM EST. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $76.10

Today's change+0.20 +0.26%
Updated January 22 3:14 PM EST. Delayed by at least 15 minutes.

USANA Health Sciences Inc Hits New 100-day High

USANA Health Sciences Inc is up today by (U.S.)$0.20 or 0.26% to (U.S.)$76.10 and setting a new 100-day high. Over the last five days, shares have gained 2.42% and 23.34% over the last 52 weeks.

Key company metrics

  • Open(U.S.) $75.90
  • Previous close(U.S.) $75.90
  • High(U.S.) $76.45
  • Low(U.S.) $75.40
  • Bid / Ask(U.S.) $75.95 / (U.S.) $76.20
  • YTD % change+2.77%
  • Volume46,858
  • Average volume (10-day)66,526
  • Average volume (1-month)77,984
  • Average volume (3-month)98,523
  • 52-week range(U.S.) $52.55 to (U.S.) $76.45
  • Beta1.01
  • Trailing P/E20.99×
  • P/E 1 year forward19.39×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.63
Updated January 22 3:14 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+8.79%

Based on its net profit margin of 8.79%, USANA Health Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.14%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jul 01, 201707/01/2017Apr 01, 201704/01/2017Dec 31, 201612/31/2016
Revenue262257255253
Total other revenue--------
Total revenue262257255253
Gross profit215213213207
Total cost of revenue47444346
Total operating expense230225222221
Selling / general / administrative183181180175
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income31323332
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax32333332
Income after tax24232122
Income tax, total8101210
Net income24232122
Total adjustments to net income--------
Net income before extra. items24232122
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items24232122
Inc. avail. to common incl. extra. items24232122
Diluted net income24232122
Dilution adjustment--------
Diluted weighted average shares25252525
Diluted EPS excluding extraordinary itemsvalue per share0.970.930.860.87
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.970.930.860.87